Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

9 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
External beam radiation therapy for recurrent or residual thyroid cancer: What is the best treatment time and the best candidate for long-term local disease control?
Cavalcante LBCP, Treistman N, Gonzalez FMTT, Fernandes PIW, Alves Junior PAG, Andrade FA, Ferreira EN, Brito TF, Pane A, Corbo R, Erlich F, Bulzico DA, Vaisman F. Cavalcante LBCP, et al. Among authors: erlich f. Head Neck. 2024 Jun;46(6):1340-1350. doi: 10.1002/hed.27702. Epub 2024 Mar 6. Head Neck. 2024. PMID: 38445804
Impact of the COVID-19 Pandemic on Radiation Oncology Departments in Brazil.
Oliveira HF, Yoshinari GH Jr, Veras IM, de Almeida WJ Jr, Freitas NMA, Castilho MS, Pellizzon ACA, Erlich F, Affonso RJ Jr, de Carvalho ÍT, Leite ACC, Kuhnen FQ, Najas RMXF, Rosa AA. Oliveira HF, et al. Among authors: erlich f. Adv Radiat Oncol. 2022 Sep-Oct;7(5):100667. doi: 10.1016/j.adro.2021.100667. Epub 2021 Feb 6. Adv Radiat Oncol. 2022. PMID: 33585726 Free PMC article.
A phase I study of mTOR inhibitor everolimus in association with cisplatin and radiotherapy for the treatment of locally advanced cervix cancer: PHOENIX I.
de Melo AC, Grazziotin-Reisner R, Erlich F, Fontes Dias MS, Moralez G, Carneiro M, Ingles Garces ÁH, Guerra Alves FV, Novaes Neto B, Fuchshuber-Moraes M, Morando J, Suarez-Kurtz G, Ferreira CG. de Melo AC, et al. Among authors: erlich f. Cancer Chemother Pharmacol. 2016 Jul;78(1):101-9. doi: 10.1007/s00280-016-3064-0. Epub 2016 May 20. Cancer Chemother Pharmacol. 2016. PMID: 27206639 Clinical Trial.
Phase 1 study of cetuximab in combination with 5-fluorouracil, cisplatin, and radiotherapy in patients with locally advanced anal canal carcinoma.
Olivatto LO, Vieira FM, Pereira BV, Victorino AP, Bezerra M, Araujo CM, Erlich F, Faroni L, Castro L, Lusis EC, Marins A, Ferreira CG. Olivatto LO, et al. Among authors: erlich f. Cancer. 2013 Aug 15;119(16):2973-80. doi: 10.1002/cncr.28045. Epub 2013 May 14. Cancer. 2013. PMID: 23674135 Free article. Clinical Trial.
Phase I trial of erlotinib combined with cisplatin and radiotherapy for patients with locally advanced cervical squamous cell cancer.
Nogueira-Rodrigues A, do Carmo CC, Viegas C, Erlich F, Camisão C, Fontão K, Lima R, Herchenhorn D, Martins RG, Moralez GM, Small IA, Ferreira CG. Nogueira-Rodrigues A, et al. Among authors: erlich f. Clin Cancer Res. 2008 Oct 1;14(19):6324-9. doi: 10.1158/1078-0432.CCR-07-5112. Clin Cancer Res. 2008. PMID: 18829516 Clinical Trial.